Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Horiuchi

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
International Journal of Cardiology|February 24, 2022
Decongestion, kidney injury and prognosis in patients with acute heart failureYu Horiuchi, Nicholas Wettersten, Dirk J van Veldhuisen, et al.
International Heart Journal|February 21, 2018
A High Level of Blood Urea Nitrogen Is a Significant Predictor for In-hospital Mortality in Patients with Acute Myocardial InfarctionYu Horiuchi, Jiro Aoki, Kengo Tanabe, et al.
ESC Heart Failure|November 3, 2022
Implications of worsening renal function before hospitalization for acute heart failureNicholas Wettersten, Stephen Duff, Yu Horiuchi, et al.
European Journal of Heart Failure|March 31, 2021
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failureNicholas Wettersten, Yu Horiuchi, Dirk J van Veldhuisen, et al.
International Journal of Cardiology. Heart & Vasculature|July 18, 2024
Prognostic impact of increase in left atrial volume following left atrial appendage closure: Insights from the OCEAN-LAAC registryHideaki Nonaka, Masahiko Asami, Yu Horiuchi, et al.
International Journal of Cardiology|May 29, 2025
Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registryHideaki Nonaka, Masahiko Asami, Yu Horiuchi, et al.
European Heart Journal|August 31, 2024
In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trialAtsushi Tanaka, Keisuke Kida, Yuya Matsue, et al.
Kidney International Reports|May 25, 2026
Randomized Trial of Finerenone on Urinary Albumin-to-Creatinine Ratio in Type 2 Diabetes Mellitus and CKDAtsushi Tanaka, Takumi Imai, Muthiah Vaduganathan, et al.
The American Journal of Cardiology|June 22, 2026
Transmitral Pressure Gradient and Residual Mitral Regurgitation After Transcatheter Edge-to-Edge Repair in Patients With and Without HemodialysisYuki Gonda, Masahiko Asami, Yu Horiuchi, et al.
Cardiovascular Diabetology|December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
International Journal of Cardiology|February 24, 2022
Decongestion, kidney injury and prognosis in patients with acute heart failureYu Horiuchi, Nicholas Wettersten, Dirk J van Veldhuisen, et al.
International Heart Journal|February 21, 2018
A High Level of Blood Urea Nitrogen Is a Significant Predictor for In-hospital Mortality in Patients with Acute Myocardial InfarctionYu Horiuchi, Jiro Aoki, Kengo Tanabe, et al.
ESC Heart Failure|November 3, 2022
Implications of worsening renal function before hospitalization for acute heart failureNicholas Wettersten, Stephen Duff, Yu Horiuchi, et al.
European Journal of Heart Failure|March 31, 2021
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failureNicholas Wettersten, Yu Horiuchi, Dirk J van Veldhuisen, et al.
International Journal of Cardiology. Heart & Vasculature|July 18, 2024
Prognostic impact of increase in left atrial volume following left atrial appendage closure: Insights from the OCEAN-LAAC registryHideaki Nonaka, Masahiko Asami, Yu Horiuchi, et al.
International Journal of Cardiology|May 29, 2025
Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registryHideaki Nonaka, Masahiko Asami, Yu Horiuchi, et al.
European Heart Journal|August 31, 2024
In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trialAtsushi Tanaka, Keisuke Kida, Yuya Matsue, et al.
Kidney International Reports|May 25, 2026
Randomized Trial of Finerenone on Urinary Albumin-to-Creatinine Ratio in Type 2 Diabetes Mellitus and CKDAtsushi Tanaka, Takumi Imai, Muthiah Vaduganathan, et al.
The American Journal of Cardiology|June 22, 2026
Transmitral Pressure Gradient and Residual Mitral Regurgitation After Transcatheter Edge-to-Edge Repair in Patients With and Without HemodialysisYuki Gonda, Masahiko Asami, Yu Horiuchi, et al.
Cardiovascular Diabetology|December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
Pageof 12